Related references
Note: Only part of the references are listed.C-Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain-of-Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23
Kelly Lauter Roszko et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse Model
Megan L. Noonan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Long-term efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in anaemia of chronic kidney disease: A meta-analysis including 13,146 patients
Huanhuan Chen et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2021)
An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk
Sara Vazquez-Sanchez et al.
FRONTIERS IN PHYSIOLOGY (2021)
Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone
Mark R. Hanudel et al.
KIDNEY INTERNATIONAL (2021)
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving (KDIGO) Conference
Jodie L. Babitt et al.
KIDNEY INTERNATIONAL (2021)
Klotho overexpression protects against renal aging along with suppression of transforming growth factor-β1 signaling pathways
Hiroaki Oishi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2021)
Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
Hong-Mou Shih et al.
JOURNAL OF BIOMEDICAL SCIENCE (2021)
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
Daniel Edmonston et al.
NATURE REVIEWS NEPHROLOGY (2020)
IRF-1 promotes renal fibrosis by downregulation of Klotho
Yan Li et al.
FASEB JOURNAL (2020)
Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure
Katharina Kurz et al.
ESC HEART FAILURE (2020)
Erythropoietin signaling in osteoblasts is required for normal bone formation and for bone loss during erythropoietin-stimulated erythropoiesis
Sukanya Suresh et al.
FASEB JOURNAL (2020)
Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes
Heike Weidner et al.
JCI INSIGHT (2020)
Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia
Annelies J. van Vuren et al.
BLOOD ADVANCES (2020)
Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
Megan L. Noonan et al.
PHYSIOLOGICAL REPORTS (2020)
Effects of erythropoietin on fibroblast growth factor 23 in mice and humans
Mark R. Hanudel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Anemia and Risk of Fractures in Older Korean Adults: A Nationwide Population-Based Study
Eun Ae Lee et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research
Annelies J. van Vuren et al.
FRONTIERS IN PHYSIOLOGY (2019)
Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet?
Insa E. Emrich et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2019)
Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia
Rafiou Agoro et al.
FASEB JOURNAL (2018)
Role of hypoxia-inducible factor-1 in the development of renal fibrosis in mouse obstructed kidney: Special references to HIF-1 dependent gene expression of profibrogenic molecules
Kazuya Kabei et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury
Luis Toro et al.
KIDNEY INTERNATIONAL (2018)
Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men
Arezoo Daryadel et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2018)
Circulating Fibroblast Growth Factor-23 Levels are Associated with an Increased Risk of Anemia Development in Patients with Nondialysis Chronic Kidney Disease
Ki Heon Nam et al.
SCIENTIFIC REPORTS (2018)
FGF23 Actions on Target Tissues-with and without Klotho
Beatrice Richter et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Acute blood loss stimulates fibroblast growth factor 23 production
Seham Rabadi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
Erica L. Clinkenbeard et al.
HAEMATOLOGICA (2017)
Osteoprotegerin and uremic osteoporosis in chronic hemodialysis patients
Diana Moldovan et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2017)
Klotho expression in osteocytes regulates bone metabolism and controls bone formation
Hirotaka Komaba et al.
KIDNEY INTERNATIONAL (2017)
Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy
Ming Chang Hu et al.
KIDNEY INTERNATIONAL (2017)
Myelodysplastic syndromes and bone loss in mice and men
H. Weidner et al.
LEUKEMIA (2017)
Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
Erica L. Clinkenbeard et al.
HAEMATOLOGICA (2017)
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword
David C. Wheeler et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2017)
FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase
Ingo Flamme et al.
PLOS ONE (2017)
Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients
Mark R. Hanudel et al.
PEDIATRIC NEPHROLOGY (2016)
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
Valentin David et al.
KIDNEY INTERNATIONAL (2016)
The hypoxia-inducible factor-1α activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia
Qian Zhang et al.
Bone Research (2016)
Klotho Prevents NFκB Translocation and Protects Endothelial Cell From Senescence Induced by Uremia
Paula Buendia et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2015)
Klotho Deficiency Disrupts Hematopoietic Stem Cell Development and Erythropoiesis
Sangeetha Vadakke Madathil et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Effects of erythropoietin on osteoblast proliferation and function
Lvhua Guo et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2014)
FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis*
Lindsay M. Coe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice
Erica L. Clinkenbeard et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis
Vincent S. Tagliabracci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism
Ming Chang Hu et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 75 (2013)
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
Yumie Rhee et al.
BONE (2011)
Fibroblast Growth Factor 23 (FGF23) and Alpha-Klotho Stimulate Osteoblastic MC3T3.E1 Cell Proliferation and Inhibit Mineralization
V. Shalhoub et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
Emily G. Farrow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Recombinant Human Erythropoietin Mitigates Reductions in Renal Klotho Expression
Hidekazu Sugiura et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
Regina Goetz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop
Vardit Lavi-Moshayoff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro
Hua Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone
Despina Sitara et al.
PLOS GENETICS (2008)
Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells
Jiang Zhu et al.
BLOOD (2007)
1,25-dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism
Thomas K. Barthel et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Bone mass density in adults with sickle cell disease
Mona Sarrai et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Klotho: An antiaging protein involved in mineral and vitamin D metabolism
P. Urena Torres et al.
KIDNEY INTERNATIONAL (2007)
Hypoxia and expression of hypoxia-inducible factor in the aging kidney
Tetsuhiro Tanaka et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2006)
Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor
GB Adams et al.
NATURE (2006)
Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations
XJ Yu et al.
BONE (2005)
Bone density and hemoglobin levels in older persons: results from the InCHIANTI study
M Cesari et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
D Sitara et al.
MATRIX BIOLOGY (2004)
Hematopoiesis is severely altered in mice with an induced osteoblast deficiency
D Visnjic et al.
BLOOD (2004)
Osteoblastic cells regulate the haematopoietic stem cell niche
LM Calvi et al.
NATURE (2003)
Share Paper
